Prevention of atrial fibrillation
91 results
1 - 91
Prevention of atrial fibrillation - Dronedarone in the prevention of atrial fibrillation - Image
- Angiotensin receptor blockers or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation
- Warfarin for preventing stroke in patients with non-valvular atrial fibrillation and no history of cerebral ischaemia
- Warfarin or antiplatelet therapy for stroke prevention in patients with non-valvular atrial fibrillation
- Factor Xa inhibitors versus vitamin K antagonists for preventing embolism in patients with atrial fibrillation
- Management of acute atrial fibrillation
- Indications for and implementation of anticoagulant therapy in atrial fibrillation
- Treatment approach for atrial fibrillation: rate control or rhythm control?
- Warfarin therapy
- Antiplatelet therapy for patients with non-valvular atrial fibrillation
- Direct oral anticoagulants versus vitamin K antangonists in non-valvular atrial fibrillation
- Choice of prophylactic medication for atrial fibrillation - Image
- Anticoagulants for non-rheumatic atrial fibrillation and a history of stroke or transient ischaemic attacks
- Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation
- Direct oral anticoagulants
- Direct oral anticoagulants versus warfarin among atrial fibrillation patients with chronic kidney disease
- Dronedarone in atrial fibrillation
- Treatment of atrial flutter
- Heart valve operation: patient follow-up and complications
- Antithrombotic agents in primary health care
- Exercise stress test
- Transient ischaemic attack (TIA)
- Selecting anticoagulant therapy in atrial fibrillation - Image
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery
- Electrical cardioversion
- Cardiac pacemakers and monitoring their function
- Mitral regurgitation
- Aortic stenosis
- Magnesium deficiency
- Hypertrophic cardiomyopathy
- Dilated cardiomyopathy
- Cerebral infarction (ischaemic stroke)
- Closure vs. medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or TIA
- Drug treatment for hypertension
- Prevention of venous thromboembolism
- Screening for thyroid disease and treatment of subclinical hypothyroidism
- Preoperative assessment
- Chronic heart failure
- Implantable cardioverter-defibrillator (ICD)
- Antiplatelet therapy for prevention of death, myocardial infarction, and stroke
- Lumbar puncture
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- Leg oedema
- Deep vein thrombosis